D.E. Shaw & Co’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $246K | Sell |
|
|||||
|
2024
Q1 | $354K | Buy |
|
|||||
|
2023
Q4 | $498K | Buy |
|
|||||
|
2023
Q3 | $213K | Sell |
|
|||||
|
2023
Q2 | $367K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $428K | Sell |
|
|||||
|
2022
Q3 | $3.14M | Sell |
|
|||||
|
2022
Q2 | $3.78M | Buy |
|
|||||
|
2022
Q1 | $3.81M | Buy |
|
|||||
|
2021
Q4 | $287K | Sell |
|
|||||
|
2021
Q3 | $806K | Sell |
|
|||||
|
2021
Q2 | $2.28M | Buy |
|
|||||
|
2021
Q1 | $769K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $153K | Sell |
|
|||||
|
2020
Q1 | $191K | Sell |
|
|||||
|
2019
Q4 | $185K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $120K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $52K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $434K | Buy |
|
|||||
|
2016
Q2 | $88K | Buy |
|